SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'PCF'


List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AZQ_A_PCFA954_0
(CATECHOL
1,2-DIOXYGENASE)		 2azq CATECHOL
1,2-DIOXYGENASE
(Pseudomonas
putida) 		9 / 9 THR A  40
LEU A  43
GLU A  53
HIS A  56
ALA A  57
TYR A  60
LEU A  61
GLU A 206
LEU A 210
 PCF  A 954 ( 4.1A)
PCF  A 954 ( 4.9A)
PCF  A 954 (-4.5A)
PCF  A 954 ( 4.5A)
PCF  A 954 (-3.5A)
PCF  A 954 (-4.1A)
None
PCF  A 954 ( 4.6A)
PCF  A 954 (-4.8A)
 0.00A 2azqA-2azqA:
45.6		 2azqA-2azqA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGN_A_PCFA1179_0
(WNT INHIBITORY
FACTOR 1)		 2ygn WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		12 / 12 LEU A  36
ILE A  40
LEU A  48
ILE A  55
MET A  63
ARG A  76
MET A  77
ILE A  80
MET A  87
PHE A  89
VAL A 152
VAL A 154
 PCF  A1179 ( 4.0A)
None
PCF  A1179 (-4.1A)
PCF  A1179 ( 4.5A)
PCF  A1179 ( 4.1A)
MLY  A  72 (-4.5A)
PCF  A1179 (-4.0A)
None
PCF  A1179 (-3.6A)
PCF  A1179 ( 3.8A)
PCF  A1179 (-4.4A)
PCF  A1179 ( 4.7A)
 0.00A 2ygnA-2ygnA:
29.7		 2ygnA-2ygnA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGN_A_PCFA1179_0
(WNT INHIBITORY
FACTOR 1)		 2ygo WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		8 / 12 ILE A  40
ILE A  55
ARG A  76
MET A  77
ILE A  80
MET A  87
PHE A  89
VAL A 152
 None
PCF  A1213 (-4.0A)
PCF  A1213 (-3.6A)
PCF  A1213 (-3.5A)
None
PCF  A1213 ( 3.8A)
PCF  A1213 (-4.1A)
PCF  A1213 ( 4.7A)
 1.08A 2ygnA-2ygoA:
28.2		 2ygnA-2ygoA:
82.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGN_A_PCFA1179_0
(WNT INHIBITORY
FACTOR 1)		 2ygo WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		11 / 12 LEU A  36
ILE A  40
LEU A  48
ILE A  55
MET A  63
MET A  77
ILE A  80
MET A  87
PHE A  89
VAL A 152
VAL A 154
 PCF  A1213 ( 4.2A)
None
PCF  A1213 (-4.3A)
PCF  A1213 (-4.0A)
PCF  A1213 ( 4.2A)
PCF  A1213 (-3.5A)
None
PCF  A1213 ( 3.8A)
PCF  A1213 (-4.1A)
PCF  A1213 ( 4.7A)
PCF  A1213 ( 4.7A)
 0.13A 2ygnA-2ygoA:
28.2		 2ygnA-2ygoA:
82.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGN_A_PCFA1179_0
(WNT INHIBITORY
FACTOR 1)		 2ygq WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		10 / 12 LEU A  36
ILE A  40
ILE A  55
MET A  63
MET A  77
ILE A  80
MET A  87
PHE A  89
VAL A 152
VAL A 154
 None
None
PCF  A1275 ( 4.4A)
PCF  A1275 ( 4.1A)
PCF  A1275 (-3.2A)
PCF  A1275 (-4.7A)
PCF  A1275 (-3.2A)
PCF  A1275 (-4.6A)
PCF  A1275 (-3.6A)
PCF  A1275 (-4.9A)
 0.42A 2ygnA-2ygqA:
26.1		 2ygnA-2ygqA:
48.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGN_A_PCFA1179_0
(WNT INHIBITORY
FACTOR 1)		 2ygq WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		10 / 12 LEU A  36
ILE A  40
LEU A  48
ILE A  55
MET A  63
MET A  77
MET A  87
PHE A  89
VAL A 152
VAL A 154
 None
None
PCF  A1275 (-4.6A)
PCF  A1275 ( 4.4A)
PCF  A1275 ( 4.1A)
PCF  A1275 (-3.2A)
PCF  A1275 (-3.2A)
PCF  A1275 (-4.6A)
PCF  A1275 (-3.6A)
PCF  A1275 (-4.9A)
 0.69A 2ygnA-2ygqA:
26.1		 2ygnA-2ygqA:
48.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGN_A_PCFA1179_0
(WNT INHIBITORY
FACTOR 1)		 2ygq WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		6 / 12 LEU A 165
ILE A  40
ILE A  55
ILE A  80
MET A  87
PHE A  89
 None
None
PCF  A1275 ( 4.4A)
PCF  A1275 (-4.7A)
PCF  A1275 (-3.2A)
PCF  A1275 (-4.6A)
 1.38A 2ygnA-2ygqA:
26.1		 2ygnA-2ygqA:
48.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGN_A_PCFA1179_0
(WNT INHIBITORY
FACTOR 1)		 2ygq WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		6 / 12 LEU A 165
ILE A  40
ILE A  55
ILE A  84
MET A  87
PHE A  89
 None
None
PCF  A1275 ( 4.4A)
None
PCF  A1275 (-3.2A)
PCF  A1275 (-4.6A)
 1.33A 2ygnA-2ygqA:
26.1		 2ygnA-2ygqA:
48.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGN_A_PCFA1179_1
(WNT INHIBITORY
FACTOR 1)		 2ygn WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		5 / 5 ILE A  49
PHE A  66
PRO A  78
VAL A 156
PHE A 173
 PCF  A1179 (-4.8A)
PCF  A1179 (-3.8A)
PCF  A1179 (-4.3A)
None
PCF  A1179 (-3.8A)
 0.00A 2ygnA-2ygnA:
29.7		 2ygnA-2ygnA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGN_A_PCFA1179_1
(WNT INHIBITORY
FACTOR 1)		 2ygo WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		5 / 5 ILE A  49
PHE A  66
PRO A  78
VAL A 156
PHE A 173
 PCF  A1213 (-4.6A)
PCF  A1213 ( 3.6A)
PCF  A1213 (-4.0A)
None
PCF  A1213 (-3.8A)
 0.26A 2ygnA-2ygoA:
28.2		 2ygnA-2ygoA:
82.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGN_A_PCFA1179_1
(WNT INHIBITORY
FACTOR 1)		 2ygq WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		4 / 5 ILE A  49
PHE A  66
VAL A 156
PHE A 173
 PCF  A1275 (-4.7A)
None
None
PCF  A1275 ( 4.5A)
 0.67A 2ygnA-2ygqA:
26.1		 2ygnA-2ygqA:
48.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGN_A_PCFA1179_1
(WNT INHIBITORY
FACTOR 1)		 2ygq WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		4 / 5 PHE A  66
PRO A  78
VAL A 156
PHE A 173
 None
PCF  A1275 (-4.1A)
None
PCF  A1275 ( 4.5A)
 0.48A 2ygnA-2ygqA:
26.1		 2ygnA-2ygqA:
48.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGO_A_PCFA1213_0
(WNT INHIBITORY
FACTOR 1)		 2ygn WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		7 / 12 LEU A  38
ILE A  40
ILE A  55
ILE A  57
ILE A  84
MET A  87
PHE A  89
 PCF  A1179 ( 4.0A)
None
PCF  A1179 ( 4.5A)
PCF  A1179 ( 4.7A)
None
PCF  A1179 (-3.6A)
PCF  A1179 ( 3.8A)
 1.30A 2ygoA-2ygnA:
28.2		 2ygoA-2ygnA:
82.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGO_A_PCFA1213_0
(WNT INHIBITORY
FACTOR 1)		 2ygn WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		12 / 12 LEU A  38
ILE A  40
ILE A  55
ILE A  57
MET A  63
PHE A  66
ILE A  80
MET A  87
PHE A  89
VAL A 152
VAL A 154
PHE A 173
 PCF  A1179 ( 4.0A)
None
PCF  A1179 ( 4.5A)
PCF  A1179 ( 4.7A)
PCF  A1179 ( 4.1A)
PCF  A1179 (-3.8A)
None
PCF  A1179 (-3.6A)
PCF  A1179 ( 3.8A)
PCF  A1179 (-4.4A)
PCF  A1179 ( 4.7A)
PCF  A1179 (-3.8A)
 0.12A 2ygoA-2ygnA:
28.2		 2ygoA-2ygnA:
82.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGO_A_PCFA1213_0
(WNT INHIBITORY
FACTOR 1)		 2ygo WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		7 / 12 LEU A  38
ILE A  40
ILE A  55
ILE A  57
ILE A  84
MET A  87
PHE A  89
 PCF  A1213 ( 3.9A)
None
PCF  A1213 (-4.0A)
PCF  A1213 ( 4.8A)
None
PCF  A1213 ( 3.8A)
PCF  A1213 (-4.1A)
 1.32A 2ygoA-2ygoA:
30.4		 2ygoA-2ygoA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGO_A_PCFA1213_0
(WNT INHIBITORY
FACTOR 1)		 2ygo WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		12 / 12 LEU A  38
ILE A  40
ILE A  55
ILE A  57
MET A  63
PHE A  66
ILE A  80
MET A  87
PHE A  89
VAL A 152
VAL A 154
PHE A 173
 PCF  A1213 ( 3.9A)
None
PCF  A1213 (-4.0A)
PCF  A1213 ( 4.8A)
PCF  A1213 ( 4.2A)
PCF  A1213 ( 3.6A)
None
PCF  A1213 ( 3.8A)
PCF  A1213 (-4.1A)
PCF  A1213 ( 4.7A)
PCF  A1213 ( 4.7A)
PCF  A1213 (-3.8A)
 0.00A 2ygoA-2ygoA:
30.4		 2ygoA-2ygoA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGO_A_PCFA1213_0
(WNT INHIBITORY
FACTOR 1)		 2ygq WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		6 / 12 ILE A  40
ILE A  55
ILE A  57
ILE A  84
PHE A  89
VAL A 152
 None
PCF  A1275 ( 4.4A)
PCF  A1275 ( 4.5A)
None
PCF  A1275 (-4.6A)
PCF  A1275 (-3.6A)
 1.39A 2ygoA-2ygqA:
26.4		 2ygoA-2ygqA:
58.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGO_A_PCFA1213_0
(WNT INHIBITORY
FACTOR 1)		 2ygq WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		6 / 12 ILE A  40
ILE A  55
ILE A  57
PHE A  66
PHE A  89
VAL A 152
 None
PCF  A1275 ( 4.4A)
PCF  A1275 ( 4.5A)
None
PCF  A1275 (-4.6A)
PCF  A1275 (-3.6A)
 1.25A 2ygoA-2ygqA:
26.4		 2ygoA-2ygqA:
58.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGO_A_PCFA1213_0
(WNT INHIBITORY
FACTOR 1)		 2ygq WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		7 / 12 LEU A  38
ILE A  40
ILE A  55
ILE A  57
ILE A  84
MET A  87
PHE A  89
 None
None
PCF  A1275 ( 4.4A)
PCF  A1275 ( 4.5A)
None
PCF  A1275 (-3.2A)
PCF  A1275 (-4.6A)
 1.29A 2ygoA-2ygqA:
26.4		 2ygoA-2ygqA:
58.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGO_A_PCFA1213_0
(WNT INHIBITORY
FACTOR 1)		 2ygq WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		12 / 12 LEU A  38
ILE A  40
ILE A  55
ILE A  57
MET A  63
PHE A  66
ILE A  80
MET A  87
PHE A  89
VAL A 152
VAL A 154
PHE A 173
 None
None
PCF  A1275 ( 4.4A)
PCF  A1275 ( 4.5A)
PCF  A1275 ( 4.1A)
None
PCF  A1275 (-4.7A)
PCF  A1275 (-3.2A)
PCF  A1275 (-4.6A)
PCF  A1275 (-3.6A)
PCF  A1275 (-4.9A)
PCF  A1275 ( 4.5A)
 0.39A 2ygoA-2ygqA:
26.4		 2ygoA-2ygqA:
58.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGO_A_PCFA1213_0
(WNT INHIBITORY
FACTOR 1)		 2ygq WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		6 / 12 LEU A  38
ILE A  40
ILE A  57
MET A  63
ILE A  80
PHE A 173
 None
None
PCF  A1275 ( 4.5A)
PCF  A1275 ( 4.1A)
PCF  A1275 (-4.7A)
PCF  A1275 ( 4.5A)
 1.10A 2ygoA-2ygqA:
26.4		 2ygoA-2ygqA:
58.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGO_A_PCFA1213_1
(WNT INHIBITORY
FACTOR 1)		 2ygn WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		5 / 6 LEU A  48
ILE A  49
MET A  77
PRO A  78
VAL A 156
 PCF  A1179 (-4.1A)
PCF  A1179 (-4.8A)
PCF  A1179 (-4.0A)
PCF  A1179 (-4.3A)
None
 0.25A 2ygoA-2ygnA:
28.2		 2ygoA-2ygnA:
82.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGO_A_PCFA1213_1
(WNT INHIBITORY
FACTOR 1)		 2ygo WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		6 / 6 LEU A  48
ILE A  49
ARG A  76
MET A  77
PRO A  78
VAL A 156
 PCF  A1213 (-4.3A)
PCF  A1213 (-4.6A)
PCF  A1213 (-3.6A)
PCF  A1213 (-3.5A)
PCF  A1213 (-4.0A)
None
 0.00A 2ygoA-2ygoA:
30.4		 2ygoA-2ygoA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGO_A_PCFA1213_1
(WNT INHIBITORY
FACTOR 1)		 2ygo WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		4 / 6 LEU A  48
ILE A  49
PRO A  78
VAL A 127
 PCF  A1213 (-4.3A)
PCF  A1213 (-4.6A)
PCF  A1213 (-4.0A)
None
 1.12A 2ygoA-2ygoA:
30.4		 2ygoA-2ygoA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGO_A_PCFA1213_1
(WNT INHIBITORY
FACTOR 1)		 2ygq WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		4 / 6 LEU A  48
ILE A  49
MET A  77
VAL A 156
 PCF  A1275 (-4.6A)
PCF  A1275 (-4.7A)
PCF  A1275 (-3.2A)
None
 0.95A 2ygoA-2ygqA:
26.4		 2ygoA-2ygqA:
58.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGP_A_PCFA1213_0
(WNT INHIBITORY
FACTOR 1)		 2ygn WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		12 / 12 LEU A  38
ILE A  40
LEU A  48
ILE A  57
MET A  87
TRP A  91
PHE A 138
PHE A 150
VAL A 152
VAL A 154
PRO A 168
PHE A 173
 PCF  A1179 ( 4.0A)
None
PCF  A1179 (-4.1A)
PCF  A1179 ( 4.7A)
PCF  A1179 (-3.6A)
None
None
None
PCF  A1179 (-4.4A)
PCF  A1179 ( 4.7A)
MLY  A 166 ( 3.9A)
PCF  A1179 (-3.8A)
 0.16A 2ygpA-2ygnA:
28.2		 2ygpA-2ygnA:
82.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGP_A_PCFA1213_0
(WNT INHIBITORY
FACTOR 1)		 2ygn WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		6 / 12 LEU A  38
ILE A  55
LEU A  48
ILE A  57
PRO A 168
PHE A 173
 PCF  A1179 ( 4.0A)
PCF  A1179 ( 4.5A)
PCF  A1179 (-4.1A)
PCF  A1179 ( 4.7A)
MLY  A 166 ( 3.9A)
PCF  A1179 (-3.8A)
 1.35A 2ygpA-2ygnA:
28.2		 2ygpA-2ygnA:
82.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGP_A_PCFA1213_0
(WNT INHIBITORY
FACTOR 1)		 2ygo WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		12 / 12 LEU A  38
ILE A  40
LEU A  48
ILE A  57
MET A  87
TRP A  91
PHE A 138
PHE A 150
VAL A 152
VAL A 154
PRO A 168
PHE A 173
 PCF  A1213 ( 3.9A)
None
PCF  A1213 (-4.3A)
PCF  A1213 ( 4.8A)
PCF  A1213 ( 3.8A)
None
None
None
PCF  A1213 ( 4.7A)
PCF  A1213 ( 4.7A)
MLY  A 166 ( 4.0A)
PCF  A1213 (-3.8A)
 0.13A 2ygpA-2ygoA:
29.0		 2ygpA-2ygoA:
99.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGP_A_PCFA1213_0
(WNT INHIBITORY
FACTOR 1)		 2ygo WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		6 / 12 LEU A  38
ILE A  55
LEU A  48
ILE A  57
PRO A 168
PHE A 173
 PCF  A1213 ( 3.9A)
PCF  A1213 (-4.0A)
PCF  A1213 (-4.3A)
PCF  A1213 ( 4.8A)
MLY  A 166 ( 4.0A)
PCF  A1213 (-3.8A)
 1.36A 2ygpA-2ygoA:
29.0		 2ygpA-2ygoA:
99.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGP_A_PCFA1213_0
(WNT INHIBITORY
FACTOR 1)		 2ygq WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		10 / 12 LEU A  38
ILE A  40
ILE A  57
MET A  87
TRP A  91
PHE A 138
PHE A 150
VAL A 152
VAL A 154
PHE A 173
 None
None
PCF  A1275 ( 4.5A)
PCF  A1275 (-3.2A)
None
None
None
PCF  A1275 (-3.6A)
PCF  A1275 (-4.9A)
PCF  A1275 ( 4.5A)
 0.39A 2ygpA-2ygqA:
26.2		 2ygpA-2ygqA:
57.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGP_A_PCFA1213_0
(WNT INHIBITORY
FACTOR 1)		 2ygq WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		9 / 12 LEU A  38
ILE A  40
LEU A  48
ILE A  57
MET A  87
TRP A  91
VAL A 152
VAL A 154
PHE A 173
 None
None
PCF  A1275 (-4.6A)
PCF  A1275 ( 4.5A)
PCF  A1275 (-3.2A)
None
PCF  A1275 (-3.6A)
PCF  A1275 (-4.9A)
PCF  A1275 ( 4.5A)
 0.66A 2ygpA-2ygqA:
26.2		 2ygpA-2ygqA:
57.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGP_A_PCFA1213_0
(WNT INHIBITORY
FACTOR 1)		 2ygq WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		10 / 12 LEU A  38
ILE A  57
MET A  87
TRP A  91
PHE A 138
PHE A 150
VAL A 152
VAL A 154
PRO A 168
PHE A 173
 None
PCF  A1275 ( 4.5A)
PCF  A1275 (-3.2A)
None
None
None
PCF  A1275 (-3.6A)
PCF  A1275 (-4.9A)
None
PCF  A1275 ( 4.5A)
 0.63A 2ygpA-2ygqA:
26.2		 2ygpA-2ygqA:
57.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGP_A_PCFA1213_1
(WNT INHIBITORY
FACTOR 1)		 2ygn WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		7 / 9 ILE A  49
ILE A  55
PHE A  66
PRO A  78
ILE A  80
PHE A  89
VAL A 156
 PCF  A1179 (-4.8A)
PCF  A1179 ( 4.5A)
PCF  A1179 (-3.8A)
PCF  A1179 (-4.3A)
None
PCF  A1179 ( 3.8A)
None
 0.26A 2ygpA-2ygnA:
28.2		 2ygpA-2ygnA:
82.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGP_A_PCFA1213_1
(WNT INHIBITORY
FACTOR 1)		 2ygn WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		6 / 9 ILE A  49
ILE A  55
PRO A  78
ILE A  80
PHE A  89
VAL A 127
 PCF  A1179 (-4.8A)
PCF  A1179 ( 4.5A)
PCF  A1179 (-4.3A)
None
PCF  A1179 ( 3.8A)
None
 1.39A 2ygpA-2ygnA:
28.2		 2ygpA-2ygnA:
82.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGP_A_PCFA1213_1
(WNT INHIBITORY
FACTOR 1)		 2ygn WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		5 / 9 ILE A  55
PHE A  66
ARG A  76
ILE A  80
PHE A  89
 PCF  A1179 ( 4.5A)
PCF  A1179 (-3.8A)
MLY  A  72 (-4.5A)
None
PCF  A1179 ( 3.8A)
 1.39A 2ygpA-2ygnA:
28.2		 2ygpA-2ygnA:
82.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGP_A_PCFA1213_1
(WNT INHIBITORY
FACTOR 1)		 2ygo WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		8 / 9 ILE A  49
ILE A  55
PHE A  66
ARG A  76
PRO A  78
ILE A  80
PHE A  89
VAL A 156
 PCF  A1213 (-4.6A)
PCF  A1213 (-4.0A)
PCF  A1213 ( 3.6A)
PCF  A1213 (-3.6A)
PCF  A1213 (-4.0A)
None
PCF  A1213 (-4.1A)
None
 0.30A 2ygpA-2ygoA:
29.0		 2ygpA-2ygoA:
99.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGP_A_PCFA1213_1
(WNT INHIBITORY
FACTOR 1)		 2ygo WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		6 / 9 ILE A  49
ILE A  55
PRO A  78
ILE A  80
PHE A  89
VAL A 127
 PCF  A1213 (-4.6A)
PCF  A1213 (-4.0A)
PCF  A1213 (-4.0A)
None
PCF  A1213 (-4.1A)
None
 1.47A 2ygpA-2ygoA:
29.0		 2ygpA-2ygoA:
99.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGP_A_PCFA1213_1
(WNT INHIBITORY
FACTOR 1)		 2ygq WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		5 / 9 ILE A  49
ILE A  55
PHE A  66
PHE A  89
VAL A 156
 PCF  A1275 (-4.7A)
PCF  A1275 ( 4.4A)
None
PCF  A1275 (-4.6A)
None
 0.67A 2ygpA-2ygqA:
26.2		 2ygpA-2ygqA:
57.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGP_A_PCFA1213_1
(WNT INHIBITORY
FACTOR 1)		 2ygq WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		6 / 9 ILE A  55
PHE A  66
PRO A  78
ILE A  80
PHE A  89
VAL A 156
 PCF  A1275 ( 4.4A)
None
PCF  A1275 (-4.1A)
PCF  A1275 (-4.7A)
PCF  A1275 (-4.6A)
None
 0.60A 2ygpA-2ygqA:
26.2		 2ygpA-2ygqA:
57.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGQ_A_PCFA1275_0
(WNT INHIBITORY
FACTOR 1)		 2ygn WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		11 / 12 LEU A  38
ILE A  40
ILE A  57
PRO A  78
ILE A  80
PRO A  81
MET A  87
PHE A  89
PHE A 103
PHE A 138
VAL A 154
 PCF  A1179 ( 4.0A)
None
PCF  A1179 ( 4.7A)
PCF  A1179 (-4.3A)
None
None
PCF  A1179 (-3.6A)
PCF  A1179 ( 3.8A)
None
None
PCF  A1179 ( 4.7A)
 0.42A 2ygqA-2ygnA:
26.1		 2ygqA-2ygnA:
48.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGQ_A_PCFA1275_0
(WNT INHIBITORY
FACTOR 1)		 2ygn WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		9 / 12 LEU A  38
ILE A  40
LEU A  48
ILE A  57
MET A  87
PHE A  89
PHE A 103
PHE A 138
VAL A 154
 PCF  A1179 ( 4.0A)
None
PCF  A1179 (-4.1A)
PCF  A1179 ( 4.7A)
PCF  A1179 (-3.6A)
PCF  A1179 ( 3.8A)
None
None
PCF  A1179 ( 4.7A)
 0.66A 2ygqA-2ygnA:
26.1		 2ygqA-2ygnA:
48.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGQ_A_PCFA1275_0
(WNT INHIBITORY
FACTOR 1)		 2ygn WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		6 / 12 LEU A  38
ILE A  40
PRO A  81
PHE A  89
PHE A 103
VAL A 154
 PCF  A1179 ( 4.0A)
None
None
PCF  A1179 ( 3.8A)
None
PCF  A1179 ( 4.7A)
 1.29A 2ygqA-2ygnA:
26.1		 2ygqA-2ygnA:
48.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGQ_A_PCFA1275_0
(WNT INHIBITORY
FACTOR 1)		 2ygo WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		11 / 12 LEU A  38
ILE A  40
ILE A  57
PRO A  78
ILE A  80
PRO A  81
MET A  87
PHE A  89
PHE A 103
PHE A 138
VAL A 154
 PCF  A1213 ( 3.9A)
None
PCF  A1213 ( 4.8A)
PCF  A1213 (-4.0A)
None
None
PCF  A1213 ( 3.8A)
PCF  A1213 (-4.1A)
None
None
PCF  A1213 ( 4.7A)
 0.52A 2ygqA-2ygoA:
26.4		 2ygqA-2ygoA:
58.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGQ_A_PCFA1275_0
(WNT INHIBITORY
FACTOR 1)		 2ygo WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		8 / 12 LEU A  38
ILE A  40
LEU A  48
ILE A  57
MET A  87
PHE A  89
PHE A 103
VAL A 154
 PCF  A1213 ( 3.9A)
None
PCF  A1213 (-4.3A)
PCF  A1213 ( 4.8A)
PCF  A1213 ( 3.8A)
PCF  A1213 (-4.1A)
None
PCF  A1213 ( 4.7A)
 0.64A 2ygqA-2ygoA:
26.4		 2ygqA-2ygoA:
58.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGQ_A_PCFA1275_0
(WNT INHIBITORY
FACTOR 1)		 2ygo WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		6 / 12 LEU A  38
ILE A  40
PRO A  81
PHE A  89
PHE A 103
VAL A 154
 PCF  A1213 ( 3.9A)
None
None
PCF  A1213 (-4.1A)
None
PCF  A1213 ( 4.7A)
 1.38A 2ygqA-2ygoA:
26.4		 2ygqA-2ygoA:
58.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YGQ_A_PCFA1275_0
(WNT INHIBITORY
FACTOR 1)		 2ygq WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		12 / 12 LEU A  38
ILE A  40
LEU A  48
ILE A  57
PRO A  78
ILE A  80
PRO A  81
MET A  87
PHE A  89
PHE A 103
PHE A 138
VAL A 154
 None
None
PCF  A1275 (-4.6A)
PCF  A1275 ( 4.5A)
PCF  A1275 (-4.1A)
PCF  A1275 (-4.7A)
PCF  A1275 (-4.6A)
PCF  A1275 (-3.2A)
PCF  A1275 (-4.6A)
PCF  A1275 (-4.6A)
None
PCF  A1275 (-4.9A)
 0.00A 2ygqA-2ygqA:
38.3		 2ygqA-2ygqA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0P_A_TE4A201_1
(BETA-LACTOGLOBULIN)		 2ygn WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		5 / 12 LEU A  48
VAL A 136
VAL A 134
PHE A  89
MET A  87
 PCF  A1179 (-4.1A)
None
PCF  A1179 ( 4.7A)
PCF  A1179 ( 3.8A)
PCF  A1179 (-3.6A)
 1.06A 4y0pA-2ygnA:
undetectable		 4y0pA-2ygnA:
18.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0P_A_TE4A201_1
(BETA-LACTOGLOBULIN)		 2ygo WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		5 / 12 LEU A  48
VAL A 136
VAL A 134
PHE A  89
MET A  87
 PCF  A1213 (-4.3A)
None
PCF  A1213 ( 4.6A)
PCF  A1213 (-4.1A)
PCF  A1213 ( 3.8A)
 1.08A 4y0pA-2ygoA:
undetectable		 4y0pA-2ygoA:
17.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0Q_A_PX9A201_0
(BETA-LACTOGLOBULIN)		 2ygn WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		5 / 12 LEU A  48
VAL A 136
VAL A 134
PHE A  89
MET A  87
 PCF  A1179 (-4.1A)
None
PCF  A1179 ( 4.7A)
PCF  A1179 ( 3.8A)
PCF  A1179 (-3.6A)
 1.11A 4y0qA-2ygnA:
undetectable		 4y0qA-2ygnA:
18.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y0Q_A_PX9A201_0
(BETA-LACTOGLOBULIN)		 2ygo WNT INHIBITORY
FACTOR 1
(Homo
sapiens) 		5 / 12 LEU A  48
VAL A 136
VAL A 134
PHE A  89
MET A  87
 PCF  A1213 (-4.3A)
None
PCF  A1213 ( 4.6A)
PCF  A1213 (-4.1A)
PCF  A1213 ( 3.8A)
 1.13A 4y0qA-2ygoA:
undetectable		 4y0qA-2ygoA:
17.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5VKQ_A_PCFA1801_0
(NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L)		 5vkq NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L
(Drosophila
melanogaster) 		5 / 6 ILE A1271
ILE A1416
LEU A1420
PHE A1422
HIS A1423
 PCF  A1801 ( 4.6A)
PCF  A1801 ( 4.8A)
PCF  A1801 (-4.7A)
PCF  A1801 (-3.8A)
PCF  A1801 (-2.7A)
 0.00A 5vkqA-5vkqA:
51.0
5vkqB-5vkqA:
50.2		 5vkqA-5vkqA:
100.00
5vkqB-5vkqA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5VKQ_A_PCFA1801_0
(NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L)		 5vkq NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L
(Drosophila
melanogaster) 		4 / 6 ILE A1301
ILE A1416
LEU A1420
HIS A1423
 None
PCF  A1801 ( 4.8A)
PCF  A1801 (-4.7A)
PCF  A1801 (-2.7A)
 0.81A 5vkqA-5vkqA:
51.0
5vkqB-5vkqA:
50.2		 5vkqA-5vkqA:
100.00
5vkqB-5vkqA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5VKQ_A_PCFA1803_0
(NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L)		 5vkq NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L
(Drosophila
melanogaster) 		6 / 10 TYR A1528
TYR A1532
LYS A1535
ILE A1536
ILE A1540
LEU A1543
 PCF  A1803 (-4.5A)
PCF  A1803 (-2.6A)
PCF  A1803 (-4.6A)
PCF  A1803 (-4.6A)
PCF  A1803 ( 4.7A)
PCF  A1803 ( 4.8A)
 0.00A 5vkqA-5vkqA:
51.0
5vkqD-5vkqA:
48.5		 5vkqA-5vkqA:
100.00
5vkqD-5vkqA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5VKQ_A_PCFA1805_0
(NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L)		 5vkq NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L
(Drosophila
melanogaster) 		5 / 7 PHE A1486
VAL A1489
HIS A1492
PRO A1493
ILE A1494
 PCF  A1805 (-3.2A)
PCF  A1805 (-3.8A)
PCF  A1805 ( 3.8A)
PCF  A1805 (-4.0A)
PCF  A1805 ( 4.5A)
 0.00A 5vkqA-5vkqA:
49.7
5vkqD-5vkqA:
48.5		 5vkqA-5vkqA:
100.00
5vkqD-5vkqA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5VKQ_A_PCFA1808_0
(NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L)		 5vkq NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L
(Drosophila
melanogaster) 		4 / 5 LEU A1437
LYS A1438
ALA A1441
LEU A1444
 PCF  A1808 ( 3.3A)
PCF  A1808 (-4.2A)
PCF  A1808 (-3.2A)
PCF  A1808 (-4.9A)
 0.15A 5vkqA-5vkqA:
49.7
5vkqD-5vkqA:
48.5		 5vkqA-5vkqA:
100.00
5vkqD-5vkqA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5VKQ_B_PCFB1802_0
(NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L)		 5vkq NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L
(Drosophila
melanogaster) 		5 / 7 PHE A1486
VAL A1489
HIS A1492
PRO A1493
ILE A1494
 PCF  A1805 (-3.2A)
PCF  A1805 (-3.8A)
PCF  A1805 ( 3.8A)
PCF  A1805 (-4.0A)
PCF  A1805 ( 4.5A)
 0.00A 5vkqA-5vkqA:
49.7
5vkqB-5vkqA:
48.6		 5vkqA-5vkqA:
100.00
5vkqB-5vkqA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5VKQ_B_PCFB1805_0
(NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L)		 5vkq NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L
(Drosophila
melanogaster) 		4 / 5 LEU A1437
LYS A1438
ALA A1441
LEU A1444
 PCF  A1808 ( 3.3A)
PCF  A1808 (-4.2A)
PCF  A1808 (-3.2A)
PCF  A1808 (-4.9A)
 0.00A 5vkqA-5vkqA:
49.7
5vkqB-5vkqA:
48.6		 5vkqA-5vkqA:
100.00
5vkqB-5vkqA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5VKQ_B_PCFB1808_0
(NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L)		 5vkq NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L
(Drosophila
melanogaster) 		6 / 10 TYR A1528
TYR A1532
LYS A1535
ILE A1536
ILE A1540
LEU A1543
 PCF  A1803 (-4.5A)
PCF  A1803 (-2.6A)
PCF  A1803 (-4.6A)
PCF  A1803 (-4.6A)
PCF  A1803 ( 4.7A)
PCF  A1803 ( 4.8A)
 0.09A 5vkqA-5vkqA:
51.0
5vkqB-5vkqA:
50.2		 5vkqA-5vkqA:
100.00
5vkqB-5vkqA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5VKQ_C_PCFC1801_0
(NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L)		 5vkq NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L
(Drosophila
melanogaster) 		6 / 9 TYR A1528
TYR A1532
LYS A1535
ILE A1536
ILE A1540
LEU A1543
 PCF  A1803 (-4.5A)
PCF  A1803 (-2.6A)
PCF  A1803 (-4.6A)
PCF  A1803 (-4.6A)
PCF  A1803 ( 4.7A)
PCF  A1803 ( 4.8A)
 0.00A 5vkqB-5vkqA:
48.6
5vkqC-5vkqA:
48.6		 5vkqB-5vkqA:
100.00
5vkqC-5vkqA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5VKQ_C_PCFC1803_0
(NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L)		 5vkq NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L
(Drosophila
melanogaster) 		6 / 8 PHE A1452
PHE A1486
VAL A1489
HIS A1492
PRO A1493
ILE A1494
 None
PCF  A1805 (-3.2A)
PCF  A1805 (-3.8A)
PCF  A1805 ( 3.8A)
PCF  A1805 (-4.0A)
PCF  A1805 ( 4.5A)
 0.00A 5vkqB-5vkqA:
48.6
5vkqC-5vkqA:
48.6		 5vkqB-5vkqA:
100.00
5vkqC-5vkqA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5VKQ_C_PCFC1805_0
(NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L)		 5vkq NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L
(Drosophila
melanogaster) 		7 / 9 GLY A1363
LEU A1364
LEU A1410
VAL A1414
ILE A1433
GLY A1434
LEU A1437
 PCF  A1807 (-3.2A)
PCF  A1807 (-4.7A)
None
None
PCF  A1807 (-3.2A)
PCF  A1807 (-2.4A)
PCF  A1808 ( 3.3A)
 0.28A 5vkqC-5vkqA:
48.6
5vkqD-5vkqA:
48.5		 5vkqC-5vkqA:
100.00
5vkqD-5vkqA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5VKQ_C_PCFC1806_0
(NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L)		 5vkq NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L
(Drosophila
melanogaster) 		4 / 5 LEU A1437
LYS A1438
ALA A1441
LEU A1444
 PCF  A1808 ( 3.3A)
PCF  A1808 (-4.2A)
PCF  A1808 (-3.2A)
PCF  A1808 (-4.9A)
 0.12A 5vkqB-5vkqA:
48.6
5vkqC-5vkqA:
48.6		 5vkqB-5vkqA:
100.00
5vkqC-5vkqA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5VKQ_D_PCFD1801_0
(NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L)		 5vkq NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L
(Drosophila
melanogaster) 		6 / 10 TYR A1528
TYR A1532
LYS A1535
ILE A1536
ILE A1540
LEU A1543
 PCF  A1803 (-4.5A)
PCF  A1803 (-2.6A)
PCF  A1803 (-4.6A)
PCF  A1803 (-4.6A)
PCF  A1803 ( 4.7A)
PCF  A1803 ( 4.8A)
 0.10A 5vkqC-5vkqA:
50.2
5vkqD-5vkqA:
48.5		 5vkqC-5vkqA:
100.00
5vkqD-5vkqA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5VKQ_D_PCFD1803_0
(NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L)		 5vkq NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L
(Drosophila
melanogaster) 		5 / 7 PHE A1486
VAL A1489
HIS A1492
PRO A1493
ILE A1494
 PCF  A1805 (-3.2A)
PCF  A1805 (-3.8A)
PCF  A1805 ( 3.8A)
PCF  A1805 (-4.0A)
PCF  A1805 ( 4.5A)
 0.16A 5vkqC-5vkqA:
48.6
5vkqD-5vkqA:
48.5		 5vkqC-5vkqA:
100.00
5vkqD-5vkqA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5VKQ_D_PCFD1806_0
(NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L)		 5vkq NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L
(Drosophila
melanogaster) 		4 / 5 LEU A1437
LYS A1438
ALA A1441
LEU A1444
 PCF  A1808 ( 3.3A)
PCF  A1808 (-4.2A)
PCF  A1808 (-3.2A)
PCF  A1808 (-4.9A)
 0.00A 5vkqC-5vkqA:
48.6
5vkqD-5vkqA:
48.5		 5vkqC-5vkqA:
100.00
5vkqD-5vkqA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5VKQ_D_PCFD1807_0
(NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L)		 5vkq NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L
(Drosophila
melanogaster) 		5 / 6 ILE A1271
ILE A1416
LEU A1420
PHE A1422
HIS A1423
 PCF  A1801 ( 4.6A)
PCF  A1801 ( 4.8A)
PCF  A1801 (-4.7A)
PCF  A1801 (-3.8A)
PCF  A1801 (-2.7A)
 0.00A 5vkqA-5vkqA:
51.0
5vkqD-5vkqA:
48.5		 5vkqA-5vkqA:
100.00
5vkqD-5vkqA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5VKQ_D_PCFD1807_0
(NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L)		 5vkq NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L
(Drosophila
melanogaster) 		4 / 6 ILE A1301
ILE A1416
LEU A1420
HIS A1423
 None
PCF  A1801 ( 4.8A)
PCF  A1801 (-4.7A)
PCF  A1801 (-2.7A)
 0.82A 5vkqA-5vkqA:
51.0
5vkqD-5vkqA:
48.5		 5vkqA-5vkqA:
100.00
5vkqD-5vkqA:
100.00